Literature DB >> 30594637

Snakebite burden in Sub-Saharan Africa: estimates from 41 countries.

Sadiq Halilu1, Garba Iliyasu1, Muhammad Hamza1, Jean-Philippe Chippaux2, Andreas Kuznik3, Abdulrazaq G Habib4.   

Abstract

There is no reliable estimate of burden of snakebite-envenoming (SBE) in Sub-Saharan Africa (SSA). We derived from a meta-analysis the burden of SBE related deaths, amputations and Post-Traumatic Stress Disorder (PTSD) in 41 countries in SSA. The annual burden was estimated at 1.03 million DALYs (95% Confidence Interval: 0.80-1.28 million DALYs). This is similar to or higher than the burden of many Neglected Tropical Diseases (NTDs) and the finding advocates for a commensurate resources allocation towards control of SBE.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Burden; Disability adjusted life years; Snakebite; Sub-Saharan Africa

Mesh：

Year:  2018        PMID： 30594637     DOI： 10.1016/j.toxicon.2018.12.002

Source DB:  PubMed          Journal:  Toxicon        ISSN： 0041-0101            Impact factor:   3.033


  10 in total

1.  An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.

Authors:  Stuart Ainsworth; Stefanie K Menzies; Nicholas R Casewell; Robert A Harrison
Journal:  PLoS Negl Trop Dis       Date:  2020-08-20

2.  Evaluation of lethality and cytotoxic effects induced by Naja ashei (large brown spitting cobra) venom and the envenomation-neutralizing efficacy of selected commercial antivenoms in Kenya.

Authors:  Ernest Z Manson; Mutinda C Kyama; Joseph K Gikunju; Josephine Kimani; James H Kimotho
Journal:  Toxicon X       Date:  2022-05-04

3.  Snakebite Treatment in Tanzania: Identifying Gaps in Community Practices and Hospital Resources.

Authors:  Felicia Margono; Anne H Outwater; Michael Lowery Wilson; Kim M Howell; Till Bärnighausen
Journal:  Int J Environ Res Public Health       Date:  2022-04-13       Impact factor: 4.614

Review 4.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546

Review 5.  Mental health conditions after snakebite: a scoping review.

Authors:  Soumyadeep Bhaumik; Sudha Kallakuri; Amanpreet Kaur; Siddhardha Devarapalli; Mercian Daniel
Journal:  BMJ Glob Health       Date:  2020-11

6.  Knowledge assessment of anti-snake venom among healthcare practitioners in northern Nigeria.

Authors:  Auwal A Bala; Abubakar I Jatau; Ismaeel Yunusa; Mustapha Mohammed; Al-Kassim H Mohammed; Abubakar M Isa; Abubakar S Wada; Kabiru A Gulma; Inuwa Bello; Sani Malami; Godpower C Michael; Basheer Az Chedi
Journal:  Ther Adv Infect Dis       Date:  2021-08-19

7.  "At the hospital they do not treat venom from snakebites": A qualitative assessment of health seeking perspectives and experiences among snakebite victims in Rwanda.

Authors:  Janna M Schurer; Aleta Dam; Marie Thérèse Mutuyimana; Daniel Muhire Runanira; Richard Nduwayezu; J Hellen Amuguni
Journal:  Toxicon X       Date:  2022-02-24

8.  Non-compartmental toxicokinetic studies of the Nigerian Naja nigricollis venom.

Authors:  Auwal A Bala; Sani Malami; Yusuf Abubakar Muhammad; Binta Kurfi; Ismaila Raji; Sanusi Muhammad Salisu; Mustapha Mohammed; George Oche Ambrose; Murtala Jibril; Jacob A Galan; Elda E Sanchez; Basheer A Z Chedi
Journal:  Toxicon X       Date:  2022-04-01

9.  Estimating economic and disease burden of snakebite in ASEAN countries using a decision analytic model.

Authors:  Chanthawat Patikorn; Jörg Blessmann; Myat Thet Nwe; Patrick Joseph G Tiglao; Taksa Vasaruchapong; Tri Maharani; Uyen Vy Doan; Syafiq Asnawi Zainal Abidin; Ahmad Khaldun Ismail; Iekhsan Othman; Suthira Taychakhoonavudh; Nathorn Chaiyakunapruk
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28

10.  In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus.

Authors:  Stefanie K Menzies; Rachel H Clare; Chunfang Xie; Adam Westhorpe; Steven R Hall; Rebecca J Edge; Jaffer Alsolaiss; Edouard Crittenden; Amy E Marriott; Robert A Harrison; Jeroen Kool; Nicholas R Casewell
Journal:  Toxicon X       Date:  2022-03-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.